Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Journal of Nephrology & Renal DiseasesISSN: 2576-3962
https://sporbahisleri.livejournal.com https://wakelet.com/@SporBahisleri67459 https://theomnibuzz.com/author/sporbahisleri/ https://lessons.drawspace.com/profile/322207/sporbahisleri/workflow https://writeupcafe.com/profile/sporbahisleri/ http://www.pearltrees.com/sporbahisleri https://pharmahub.org/members/26874/blog https://www.zupyak.com/u/Spor-Bahisleri/ https://www.metroflog.co/sporbahisleri https://www.fuzia.com/fz/spor-bahisleri https://tr.pinterest.com/sporbahislerim/ https://my.getjealous.com/sporbahisleri https://sporbahisleri.contently.com https://hubpages.com/@sporbahisleri https://www.tumblr.com/sporbahisleri https://hub.docker.com/u/sporbahislerim https://betsiteleri.blogfree.net https://betsiteleri.amebaownd.com https://sporbahisleri.pixnet.net/blog https://betsiteleri.seesaa.net https://betsiteleri.threadless.com https://betsiteleri.neocities.org https://bahissiteleri.localinfo.jp https://betsiteleri.shopinfo.jp https://teletype.in/@betsiteleri https://ubl.xml.org/users/sporbahisleri https://betsiteleri.educatorpages.com https://betsiteleri.onlc.fr https://sporbahisleri.gumroad.com
Shutov E.V. Author
Subjects of specialization
Affiliation
Kidney Dis-function
Botkin Clinical City Hospital, Russian Medical Academy of Continuous Professional Education, Moscow, Russia
Biography
Prof. Shutov E.V. is working many years on the problem of treating patients with ?KD. He heads the largest nephrology center in Russia, where there are excellent results in clinical outcomes (dialysis patients mortality 6-7% per year). He uses his own algorithms for treating complications in these patients (anemia, CKD -MBD, infections, hydration, cardiovascular disease).
Publications
Annual Meeting Abstract Open Access
New possibilities in the treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
Author(s): Shutov E.V.
Despite the understanding of the problem of treatment CKD-MBD, success in the treatment of this pathology is very modest. This was primarily due to the absent of effective drugs to achieve target biochemical parameters. Recently, new phosphate binders containing iron and calcimimetics have become available for treatment of CKDMBD. The aim of the study was to assess the effect of new drugs on CKD-MBD targets, including FGF-23, Klotho, PTH, P, Ca and others. We got a good effect from the use of a combination of calcimimetics and phosphate binders containing iron. Only an assessment of the changes in all disease markers under the influence of new drugs gave us the opportunity to improve approaches to treating CKDMBD. Conclusions: Based on our own research results, we can conclude that in t... view more»
Google Scholars / Researchers Sites
